Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

James Michael Kirshenbaum, M.D.

TitleAssociate Professor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressBrigham and Women's Hospital
Cardiology
75 Francis St
Boston MA 02115
Phone617/732-7173
Fax617/732-7134

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Marchini J, Morrow D, Resnic F, Manica A, Kirshenbaum J, Cannon C, Croce K. An algorithm for use of prasugrel (effient) in patients undergoing cardiac catheterization and percutaneous coronary intervention. Crit Pathw Cardiol. 2010 Dec; 9(4):192-8.
    View in: PubMed
  2. Punnoose LR, Roh JD, Hu S, Udell JA, Wagle N, Kirshenbaum JM, Lacasce AS. Cardiac presentation of anaplastic large-cell lymphoma. J Clin Oncol. 2010 Jul 1; 28(19):e314-6.
    View in: PubMed
  3. Maron BA, Goldhaber SZ, Sturzu AC, Rhee DK, Ali BS, Shah PB, Kirshenbaum JM. Catheter-directed thrombolysis for giant right atrial thrombus. Circ Cardiovasc Imaging. 2010 Jan; 3(1):126-7.
    View in: PubMed
  4. Goldszer RC, Moore ML, Hird L, Kirshenbaum JM, et al. . Process improvements to support eairler discaharge times on a cardiology serviece. J of Clinical Outcomes Management. 2003; 10:263-265.
  5. Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV, Ohno-Machado L, Kirshenbaum JM, Rogers CD, Popma JJ, Piana R. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 2003 Jan; 145(1):42-6.
    View in: PubMed
  6. Simon DI, Liu CB, Ganz P, Kirshenbaum JM, Piana RN, Rogers C, Selwyn AP, Popma JJ. A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheter Cardiovasc Interv. 2001 Apr; 52(4):425-32.
    View in: PubMed
  7. Pierce GL, Seferlis C, Kirshenbaum J, Hartley LH. Lack of association of exercise testing with coronary stent closure. Am J Cardiol. 2000 Dec 1; 86(11):1259-61, A6.
    View in: PubMed
  8. Delacretaz E, Kirshenbaum JM, Friedman PL. Prinzmetal's angina. Circulation. 2000 Mar 21; 101(11):E107-8.
    View in: PubMed
  9. Lin CB, Popma JJ, Chan S, Ganz P, Kirshenbaum JM, Piana RN, Rogers C, Selwyn AP, Simon DI. Comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergiong percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Circulation. 2000; 102:II-418.
  10. Stone PH, Thompson B, Zaret BL, Chaitman B, Gibson RS, Schweiger MJ, Steingart R, Kirshenbaum J, Thompson C, Fung A, McCabe CH, Knatterud GL, Braunwald E. Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study. Eur Heart J. 1999 Aug; 20(15):1084-93.
    View in: PubMed
  11. Kirshenbaum JM. Management of Stable and Unstable Angina Pectoris. Physicians on Line: Controversies in Cardiology CME. 1998.
  12. Cannon CP, Thompson B, McCabe CH, Mueller HS, Kirshenbaum JM, Herson S, Nasmith JB, Chaitman BR, Braunwald E. Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials. Am J Cardiol. 1995 May 15; 75(15):977-81.
    View in: PubMed
  13. Hauptman PJ, Pashos CL, Kirshenbaum JM, Guadagnoli E, Flather MD. Clinical Dilemas and Policy Controversies in Early Management of Acute Myocardial Infarction. JCOM. 1995; 2:9-30.
  14. Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD, et al. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. J Am Coll Cardiol. 1994 Dec; 24(7):1602-10.
    View in: PubMed
  15. Hickey ML, Rossi L, Vander Vliet M, Kirshenbaum JM, Komaroff AL, Lee TH, Burstin H. Gender differences in health status prior to coronary revascularization. Circulation. 1994; 90(Suppl I):I-349.
  16. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI-IIIB trial. Circulation. 1994; 89:1545-1156.
  17. Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD, Palmeri S, Dangoisse V, Flaker GC, Davis V, Chaitman, Wackers FJTh, Zaret BL, Gibson CM, Poole WK, Braunwald E. Clinical benefit of front-loaded tPA over combination thrombolytic therapy or APSAC for acute MI: results of the TIMI 4 trial. Circulation. 1993; 88(Suppl I):I-291.
  18. Kirshenbaum JM. Therapy for acute myocardial infarction: an update. Heart Dis Stroke. 1992 Jul-Aug; 1(4):211-7.
    View in: PubMed
  19. Kirshenbaum JM. Therapy of Acute Myocardial Infarction: An Update. Heart Disease and Stroke. 1992; 1:211-217.
  20. Kirshenbaum JM, Bahr RD, Flaherty JT, Gurewich V, Levine HJ, Loscalzo J, Schumacher RR, Topol EJ, Wahr DW, Braunwald E. Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group. Am J Cardiol. 1991 Dec 15; 68(17):1564-9.
    View in: PubMed
  21. Carvalho PA, Vekshtein VI, Tumeh SS, Alajaji G, Nagel JS, Kirshenbaum J, DeSisto WC, Holman BL. Tc-99m MIBI SPECT in the assessment of myocardial reperfusion after percutaneous transluminal coronary angioplasty. Clin Nucl Med. 1991 Nov; 16(11):819-25.
    View in: PubMed
  22. Ryan TJ, Kirshenbaum JM. Coronary angioplasty in acute myocardial infarction. J Myocardial Ischemia. 1991; 3:37-50.
  23. Tischler MD, Lee RT, Kirshenbaum JM. Successful treatment of prosthetic tricuspid valve thrombosis with short-course recombinant tissue-type plasminogen activator. Am Heart J. 1990 Oct; 120(4):975-7.
    View in: PubMed
  24. Kirshenbaum JM, Flaherty JT, Bahr RD, Levine HJ, Loscalzo J, Schumacher R, Topol EJ, Wahr D, and Braunwald E. Coronary thrombolysis with low-dose synergistic combinations of prourokinase and recombinant tissue plasminogen activator. Circulation. 1990; 82((Suppl III):III-537.
  25. Kuo PC, Kirshenbaum JM, Gordon J, Laffel G, Young P, DiSesa VJ, Mudge GH, Vaughan DE. Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients. Am J Cardiol. 1989 Sep 15; 64(10):631-5.
    View in: PubMed
  26. Kirshenbaum JM. Nonthrombolytic intervention in acute myocardial infarction. Am J Cardiol. 1989 Jul 18; 64(4):25B-28B.
    View in: PubMed
  27. Loscalzo J, Wharton TP, Kirshenbaum JM, Levine HJ, Flaherty JT, Topol EJ, Ramaswamy K, Kosowsky BD, Salem DN, Ganz P, et al. Clot-selective coronary thrombolysis with pro-urokinase. Circulation. 1989 Apr; 79(4):776-82.
    View in: PubMed
  28. Lee RT, Bhatia SJ, Kirshenbaum JM, Friedman PL. Left ventricular tamponade: echocardiographic and hemodynamic manifestations. Clin Cardiol. 1989 Feb; 12(2):102-4.
    View in: PubMed
  29. Kirshenbaum JM. Thrombolysis and angioplasty in acute myocardial infarction. Management Options in Cardiology. 1989; 1:4-5.
  30. Stamler JS, Vaughan DE, Rudd MA, Mudge GH, Kirshenbaum J, Young P, Alexander RW, Loscalzo J. Frequency of hypercholesterolemia after cardiac transplantation. Am J Cardiol. 1988 Dec 1; 62(17):1268-72.
    View in: PubMed
  31. Kirshenbaum JM, Kloner RF, McGowan N, Antman EM. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy. J Am Coll Cardiol. 1988 Sep; 12(3):773-80.
    View in: PubMed
  32. Vaughan DE, Kirshenbaum JM, Loscalzo J. Streptokinase-induced, antibody-mediated platelet aggregation: a potential cause of clot propagation in vivo. J Am Coll Cardiol. 1988 Jun; 11(6):1343-8.
    View in: PubMed
  33. Manji N, Hulyalkar AR, Keroack MA, Vekshtein VI, Kirshenbaum JM, Sugarman DI, Chopra S. Cutaneous pseudo abscesses: an unusual presentation of severe pancreatitis. Am J Gastroenterol. 1988 Feb; 83(2):177-9.
    View in: PubMed
  34. Fish RD, Nabel EG, Selwyn AP, Ludmer PL, Mudge GH, Kirshenbaum JM, Schoen FJ, Alexander RW, Ganz P. Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest. 1988 Jan; 81(1):21-31.
    View in: PubMed
  35. Bhatia SJ, Kirshenbaum JM, Shemin RJ, Cohn LH, Collins JJ, Di Sesa VJ, Young PJ, Mudge GH, Sutton MG. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation. 1987 Oct; 76(4):819-26.
    View in: PubMed
  36. Brasier AR, Macklis JD, Vaughan D, Warner L, Kirshenbaum JM. Myopericarditis as an initial presentation of meningococcemia. Unusual manifestation of infection with serotype W135. Am J Med. 1987 Mar 23; 82(3 Spec No):641-4.
    View in: PubMed
  37. Vaughan DE, Kirshenbaum JM, Loscalzo J. Platelet aggregation induced by streptokinase in the presence of specific antibodies. Circulation. 1987; 76(Suppl IV):IV-100.
  38. Kirshenbaum JM, Antman E, McGowan N, Kloner P. Use of esmolol in patients with acute myocardial ischemia and contraindications to beta blockade. J Am Coll Cardiol. 1987; 9(Suppl A):24A.
  39. Bhatia S, Kirshenbaum JM, Shemin R, Cohn L, Collins J, DiSesa V, Mudge G, St. John Sutton M. Time course of resolution of pulmonary hypertension and right ventricular remodeling after cardiac transplantation. J Am Coll Cardiol. 1987; 9(Suppl A):31A.
  40. Friedman PL, Shook TL, Kirshenbaum JM, Selwyn AP, Ganz P. Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty. Circulation. 1986 Aug; 74(2):330-9.
    View in: PubMed
  41. Sung RJ, Blanski L, Kirshenbaum J, MacCosbe P, Turlapaty P, Laddu AR. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia. J Clin Pharmacol. 1986 Mar; 26 Suppl A:A15-A26.
    View in: PubMed
  42. Campbell S, Holman BL, Kirshenbaum JM, Antman EM, Lister-James J, Davison A, Dozlowski J, English RJ, Jones AG. The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99-m hexakis (t-butylisonitrile) technetium (I) (TBI), a new myocardial imaging agent. European J Nucl Med. 1986; 12:219-225.
  43. Shemin RJ, Young P, Kirshenbaum JM, Mudge GH, Schoen F, DiSesa VJ, Cohn LH, Collins JJ. Acute rejection: Treatment results in a new heart transplant program. J Heart Transp. 1986; 5:53.
  44. Campbell S, Holman BL, Kirshenbaum JM, Antman EM, Lister-James J, Davison A, Kozlowski J, English RJ, Jones AG. The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agent. Eur J Nucl Med. 1986; 12(5-6):219-25.
    View in: PubMed
  45. Levin DC, Boxt LM, Abben R, Garnic JD, Kirshenbaum JM, Adler D, Shook T, Friedman P, Ganz P. Sequential balloon technique in angioplasty of severe coronary arterial obstructions. Am J Cardiol. 1985 Nov 1; 56(12):789-91.
    View in: PubMed
  46. Kloner RA, Kirshenbaum J, Lange R, Antman EM, Braunwald E. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia. Am J Cardiol. 1985 Oct 23; 56(11):40F-48F.
    View in: PubMed
  47. Kirshenbaum JM, Kloner RA, Antman EM, Braunwald E. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia. Circulation. 1985 Oct; 72(4):873-80.
    View in: PubMed
  48. Kirshenbaum JM, Lorell BH, Schoen FJ, Bettmann MA, Thompson GB. Angioinvasive pulmonary aspergillosis: presentation as massive pulmonary saddle embolism in an immunocompromised patient. J Am Coll Cardiol. 1985 Aug; 6(2):486-9.
    View in: PubMed
  49. Kirshenbaum JM, Smith TW. Mitral valve surgery: Reconstruction vs. Replacement. Lifeline. 1985; 3:1-16.
  50. Campbell S, Holman BL, Kirshenbaum JM, Jones AG, Lister-James J, Davison, A. Antman EM. Radionuclide imaging of myocardial infarction using Tc-99m TBI. Circulation. 1985; 72(Suppl III):III-443.
  51. Holman BL, Jones AG, Lister-James J, Davison A, Abrams MJ, Kirshenbaum JM, Tumeh SS, English RJ. A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human. J Nucl Med. 1984 Dec; 25(12):1350-5.
    View in: PubMed
  52. Shook TL, Kirshenbaum JM, Hundley RF, Shorey JM, Lamas GA. Ethanol intoxication complicating intravenous nitroglycerin therapy. Ann Intern Med. 1984 Oct; 101(4):498-9.
    View in: PubMed
  53. Holman BL, Jones AG, Lister-James J, Davison A, Abrams MJ, Kirshenbaum JM, Tumeh SS, English RJ. A new Tc-99m-labeled myocardial imaging agent, hexakis (t-utylisonitrile-technetium (I) (Tc-99m TBI): initial experience in the human. J Nucl Med. 1984; 25:1350-1355.
  54. Kirshenbaum JM, Stone PH. Left main artery disease: noninvasive detection. Primary Cardiology. 1984; 10:87-101.
  55. Mitch WE, Johnson MW, Kirshenbaum JM, Lopez RE. Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharmacol Ther. 1981 Mar; 29(3):318-21.
    View in: PubMed
  56. Mitch WE, Johnson MW, Kirshenbaum JM, Lopez RE . Effect of large doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharm Ther. 1981; 29:318-321.
  57. Wheeler JE, Enterline HT, Roseman JM, Tomasulo JP, McIlvaine CH, Fitts WT, Kirshenbaum J. Lobular carcinoma in situ of the breast. Long-term followup. Cancer. 1974 Sep; 34(3):554-63.
    View in: PubMed
  58. Fox RR, Laird CW, Kirshenbaum J, Meier H. Effect of strain, sex, and circadian rhythm on rabbit serum bilirubin and iron levels. Proc Soc Exp Biol Med. 1974 Feb; 145(2):421-7.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Kirshenbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (201) concept(s)
_
Co-Authors
See all (24) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_